BiomX Inc. (NYSEAMERICAN:PHGE) Short Interest Update

BiomX Inc. (NYSEAMERICAN:PHGE) was the target of a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 55,500 shares, a decline of 18.4% from the November 15th total of 68,000 shares. Based on an average daily trading volume, of 86,400 shares, the short-interest ratio is presently 0.6 days. Currently, 0.5% of the shares of the company are short sold.

BiomX Price Performance

Shares of PHGE remained flat at $0.63 during mid-day trading on Friday. 32,380 shares of the stock traded hands, compared to its average volume of 108,822. The company has a market capitalization of $11.53 million, a PE ratio of -0.20 and a beta of 1.31. BiomX has a 12 month low of $0.48 and a 12 month high of $8.55.

About BiomX

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).